MyoKardia Inc.

MyoKardia Inc.
Stock Exchange Frankfurt Stock Exchange
EPS
-
Market Cap
-
Shares Outstanding
40.12 M
Public Float
25.85 M
MyoKardia Inc.
Stock Exchange NASDAQ Stock Market
EPS
$2.2
Market Cap
$2.27 B
Shares Outstanding
46.07 M
Public Float
37.89 M

Profile

Address
333 Allerton Avenue
San Francisco California 94080
United States
Employees -
Website http://www.myokardia.com
Updated 07/08/2019
MyoKardia, Inc. operates as a biopharmaceutical company. It engages in the discovery, development, and commercialization of targeted therapies for the treatment of cardiovascular diseases. The firm focuses on the treatment of heritable cardiomyopathies, genetically-driven forms of heart failure that result from biomechanical defects in cardiac muscle contraction.

Financials

View All

Anastasios E. Gianakakos
President, Chief Executive Officer & Director
David P. Meeker
Independent Director